Michael E Menefee Selected Research

Michael E Menefee Research Topics

7	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 10/2010
7	Neoplasms (Cancer) 01/2020 - 10/2012
4	Anaplastic Thyroid Carcinoma 01/2020 - 10/2010
4	Disease Progression 01/2019 - 10/2010
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2013 - 01/2012
2	medullary Thyroid cancer 10/2017 - 05/2014
2	Fatigue 05/2014 - 10/2010
2	Hypertension (High Blood Pressure) 05/2014 - 09/2012
2	Hypopigmentation (Hypomelanosis) 10/2010 - 07/2010
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Papillary Thyroid Cancer 01/2020
1	Hypokalemia 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Adrenocortical Carcinoma 01/2019
1	Diarrhea 05/2014
1	Triple Negative Breast Neoplasms 10/2012
1	Pain (Aches) 09/2012
1	Nausea 10/2010

6	pazopanib FDA Link 01/2020 - 07/2010
3	Tyrosine Kinase InhibitorsIBA 10/2017 - 07/2010
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2017 - 01/2012
2	IodineIBA 01/2020 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 10/2017 - 01/2012
2	Pharmaceutical PreparationsIBA 10/2012 - 10/2010
2	Phosphotransferases (Kinase)IBA 09/2012 - 10/2010
1	Thyroglobulin FDA Link 01/2020
1	GossypolIBA 01/2019
1	gossypol acetic acidIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	TroponinIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2018
1	veliparibIBA 01/2018
1	lenvatinibIBA 10/2017
1	cabozantinibIBA 10/2017
1	ixabepilone (BMS 247550)FDA Link 01/2013
1	temsirolimus FDA Link 01/2013
1	epothilone B (EPO906)IBA 01/2013
1	Decitabine FDA Link 10/2012
1	romidepsin (FK228)FDA Link 10/2012
1	MethyltransferasesIBA 10/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	Sunitinib (Sutent)FDA Link 01/2012
1	Axitinib (AG 013736)IBA 01/2012
1	Tyrosine (L-Tyrosine)FDA Link 10/2010